Main Menu

Inhalation Research Services
Instruments
Publications
Webinars
About
Investors / investerare
Contact

Inhalation Research Services
Instruments
Publications
Webinars
About
Investors / investerare
Contact

Meet new ISAB Board member Jan Hellqvist: “there is a major opportunity for ISAB as a service provider for SME respiratory drug developers”
Inhalation Sciences presents comprehensive new strategy update
Webinar with Snezana Radivojev, Dr. Scient. Med. 27 April 2022, at 4:00 PM CET
SOT 2022 – 61st annual meeting, 27-31 March
Join CEO Manoush Masarrat in a Redeye interview, March 9, 2022
Upcoming investor relations activities 2022
Inhalation Sciences´ webinar on inhalable generic drugs
ISAB ramps up remote installation and digital training with third major project – client: ’PreciseInhale will become central in our developments of formulations for inhalation’
Inhalation Sciences news roundup spring 2021
Inhalation Sciences news roundup fall 2020

Upcoming investor relations activities 2022

1 februari, 2022
13:49

Follow Inhalation Sciences investor relations activities in the first half of 2022

« Inhalation Sciences´ webinar on inhalable generic drugs

Join CEO Manoush Masarrat in a Redeye interview, March 9, 2022 »

Contact

Hälsovägen 7
Novum Floor 6, Elevator E
141 57 Huddinge, Sweden.
contact@inhalation.se
+46 (0) 705 625 195

Visitor entrance: Blickagången 6, Floor 6, Elevator E

Useful links

Inhalation Research Services
Instruments
Publications
Webinars
About
Investors / investerare
Contact

About Us

Inhalation Sciences is a cutting-edge Contract Research Organization (CRO) specializing in inhalation drug development. Leveraging our proprietary technology platform, PreciseInhale®, we empower our clients to de-risk and accelerate their R&D pipelines by delivering high-resolution, predictive data early in the development process.

Copyright © 2025 Inhalation. All rights reserved.

Design mkmedia

To top